Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Accumulated Expenses: 2019-2025

Historic Accumulated Expenses for Benitec Biopharma (BNTC) over the last 5 years, with Mar 2025 value amounting to $426,000.

  • Benitec Biopharma's Accumulated Expenses fell 17.60% to $426,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $426,000, marking a year-over-year decrease of 17.60%. This contributed to the annual value of $475,000 for FY2024, which is 0.64% up from last year.
  • Benitec Biopharma's Accumulated Expenses amounted to $426,000 in Q1 2025, which was down 20.67% from $537,000 recorded in Q4 2024.
  • Benitec Biopharma's 5-year Accumulated Expenses high stood at $537,000 for Q4 2024, and its period low was $231,000 during Q1 2021.
  • Moreover, its 3-year median value for Accumulated Expenses was $475,000 (2024), whereas its average is $481,556.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first soared by 54.55% in 2022, then decreased by 17.60% in 2025.
  • Over the past 5 years, Benitec Biopharma's Accumulated Expenses (Quarterly) stood at $321,000 in 2021, then increased by 23.36% to $396,000 in 2022, then skyrocketed by 32.07% to $523,000 in 2023, then increased by 2.68% to $537,000 in 2024, then decreased by 17.60% to $426,000 in 2025.
  • Its last three reported values are $426,000 in Q1 2025, $537,000 for Q4 2024, and $495,000 during Q3 2024.